Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Silberstein, SD
2004.
Migraine Pathophysiology and its Clinical Implications.
Cephalalgia,
Vol. 24,
Issue. 2_suppl,
p.
2.
Cahill, CM
and
Murphy, KC
2004.
Migraine and Depersonalization Disorder.
Cephalalgia,
Vol. 24,
Issue. 8,
p.
686.
Peres, MFP
Zukerman, E
Soares, CA Senne
Alonso, EO
Santos, BFC
and
Faulhaber, MHW
2004.
Cerebrospinal Fluid Glutamate Levels in Chronic Migraine.
Cephalalgia,
Vol. 24,
Issue. 9,
p.
735.
Buchanan, Thomas M
Ramadan, Nabih M
and
Aurora, Sheena
2004.
Future pharmacologic targets for acute and preventive treatments of migraine.
Expert Review of Neurotherapeutics,
Vol. 4,
Issue. 3,
p.
391.
Peres, MFP
2005.
Melatonin, the Pineal Gland and their Implications for Headache Disorders.
Cephalalgia,
Vol. 25,
Issue. 6,
p.
403.
Lim, EC-H
Wilder-Smith, EPV
Chong, JLM
and
Wong, M-C
2005.
Seeing the Light: Brainstem Glioma Causing Visual Auras and Migraine.
Cephalalgia,
Vol. 25,
Issue. 2,
p.
154.
Ramadan, Nabih M.
2005.
Targeting therapy for migraine.
Neurology,
Vol. 64,
Issue. 10_suppl_2,
Oshinsky, Michael L.
and
Luo, Jia
2006.
Neurochemistry of Trigeminal Activation in an Animal Model of Migraine.
Headache: The Journal of Head and Face Pain,
Vol. 46,
Issue. s1,
Ramadan, Nabih M.
and
Buchanan, Thomas M.
2006.
New and future migraine therapy.
Pharmacology & Therapeutics,
Vol. 112,
Issue. 1,
p.
199.
Peres, Mario FP
Masruha, Marcelo R
Zukerman, Eliova
Moreira-Filho, Carlos Alberto
and
Cavalheiro, Esper A
2006.
Potential therapeutic use of melatonin in migraine and other headache disorders.
Expert Opinion on Investigational Drugs,
Vol. 15,
Issue. 4,
p.
367.
Arulmani, U
Gupta, S
VanDenBrink, A Maassen
Centurión, D
Villalón, CM
and
Saxena, PR
2006.
Experimental Migraine Models and Their Relevance in Migraine Therapy.
Cephalalgia,
Vol. 26,
Issue. 6,
p.
642.
Peres, Mario F. P.
2006.
Neuroendocrine Correlates of Sleep/Wakefulness.
p.
355.
ÅBERG, N. DAVID
2006.
The Somatotrophic Axis in Brain Function.
p.
147.
Samsam, M.
Coveñas, R.
Ahangari, R.
Yajeya, J.
and
Narváez, J.A.
2007.
Role of neuropeptides in migraine: where do they stand in the latest expert recommendations in migraine treatment?.
Drug Development Research,
Vol. 68,
Issue. 6,
p.
294.
Pratt, Wanda
and
Yetisgen-Yildiz, Meliha
2007.
Response to ‘‘Validating discovery in literature-based discovery”.
Journal of Biomedical Informatics,
Vol. 40,
Issue. 4,
p.
450.
Siniatchkin, Michael
Kröner‐Herwig, Birgit
Kocabiyik, Ebru
and
Rothenberger, Aribert
2007.
Intracortical Inhibition and Facilitation in Migraine—A Transcranial Magnetic Stimulation Study.
Headache: The Journal of Head and Face Pain,
Vol. 47,
Issue. 3,
p.
364.
Vieira, Domingos Sávio deSouza
Naffah‐Mazzacoratti, Maria da Graça
Zukerman, Eliova
Soares, Carlos Augusto Senne
Cavalheiro, Esper Abräo
and
Peres, Mario Fernando Prieto
2007.
Glutamate Levels in Cerebrospinal Fluid and Triptans Overuse in Chronic Migraine.
Headache: The Journal of Head and Face Pain,
Vol. 47,
Issue. 6,
p.
842.
Hargreaves, Richard
2007.
New Migraine and Pain Research.
Headache: The Journal of Head and Face Pain,
Vol. 47,
Issue. s1,
Oshinsky, Michael L.
and
Gomonchareonsiri, Sumittra
2007.
Episodic Dural Stimulation in Awake Rats: A Model for Recurrent Headache.
Headache: The Journal of Head and Face Pain,
Vol. 47,
Issue. 7,
p.
1026.
Johnson, Matthew P
Fernandez, Francesca
Colson, Natalie J
and
Griffiths, Lyn R
2007.
A pharmacogenomic evaluation of migraine therapy.
Expert Opinion on Pharmacotherapy,
Vol. 8,
Issue. 12,
p.
1821.